Intellectia LogoIntellectia
Product
Resources
Markets
News
Partner Program
Pricing
Log inTry for Free
Intellectia Logo
Log in
Intellectia Logo

Product

Features
Financial AI Agent
Stock Technical Analysis
Stock Monitor
Hedge Fund Tracker
AI Screener
Trading Strategies
AI Stock Picker
Swing Trading
Quant AI
Stock Chart Patterns
Daytrading Center
AI Earnings Prediction
Whales Auto Tracker
Backtesting Playground

Resources

Learn
Blog
Earnings
Tutorial
Help Center
Company
About Us
Contact
Press
Reward Program
Partner Program
Tools
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Compare
TradingView
SeekingAlpha

Markets

Trending Stocks
Hot Crypto
Trending News
All Stocks

News

Trading News
Overview
Top News
Daily Market Brief
Earnings
Latest
Newswire
Stock News
Crypto News
Monitor News
Partner ProgramPricing
Start for Free
  1. Home
    2. >
  2. Stock
    3. >
  3. MED
stocks logo

MED

-
collectAdd to Watchlistadvanced chartAdvanced Chart
$
0.000
0(0.000%)1D
collectadvanced chart
    Overview
    Forecast
    Valuation
    Earnings
High
--
Open
--
VWAP
--
Vol
--
Mkt Cap
--
Low
--
Amount
--
EV/EBITDA(TTM)
--
Total Shares
--
EV
--
EV/OCF(TTM)
--
P/S(TTM)
--
Intellectia AI SwingMax
Intellectia AI SwingMax

Market Estimates

Earnings Estimates
Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2025Q4
FY2026Q1
FY2026Q2
71.40M
-40%
-0.450
-550%
85.50M
-26.12%
-0.380
+442.86%
88.70M
-15.97%
-0.330
-250%
Estimates Revision
The market is revising Downward the revenue expectations for Medifast, Inc. (MED) for FY2025, with the revenue forecasts being adjusted by -0.7% over the past three months. During the same period, the stock price has changed by -19.85%.
Revenue Estimates for FY2025
Revise Downward
down Image
-0.7%
In Past 3 Month
EPS Estimates for FY2025
Revise Downward
down Image
-86.67%
In Past 3 Month
Stock Price
Go Down
down Image
-19.85%
In Past 3 Month

Valuation Metrics

The current forward P/E ratio for Medifast Inc (MED.N) is -6.43, compared to its 5-year average forward P/E of 11.38. For a more detailed relative valuation and DCF analysis to assess Medifast Inc 's fair value, click here.
  • Forward PE
  • Forward EV/EBITDA
  • Forward PS

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PE
11.38
Current PE
-6.43
Overvalued PE
77.35
Undervalued PE
-54.58

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average EV/EBITDA
6.93
Current EV/EBITDA
0.00
Overvalued EV/EBITDA
10.76
Undervalued EV/EBITDA
3.10

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PS
0.98
Current PS
0.00
Overvalued PS
1.53
Undervalued PS
0.42
AI Stock Picker
AI Stock Picker

Financials

Annual
Quarterly
N/A
Total Revenue
N/A
Operating Profit
N/A
Net Income after Tax
N/A
EPS - Diluted
N/A
Free Cash Flow
N/A
Gross Profit Margin - %
N/A
FCF Margin - %
N/A
Net Margin - %
N/A
ROIC

Trading Trends

  • Insider
  • Hedge Fund
  • Congress Trading
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
Bought
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Financial AI Agent
Financial AI Agent

MED News & Events

Events Timeline

(ET)
2025-11-03
16:13:09
Medifast Reports Q4 EPS of $1.25, Exceeding Estimate of 45 Cents by 70 Cents
select
2025-11-03
16:12:15
Medifast Announces Q3 Earnings Per Share of 21 Cents, Below Estimate of 36 Cents
select
2025-08-04 (ET)
2025-08-04
16:16:02
Medifast sees Q2 EPS (60c)-0c, one estimate (30c)
select
Sign Up For More Events
Sign Up For More Events

News

[object Object]
Preview
8.0
11-06NASDAQ.COM
Significant Wednesday Options Trading: RKLB, EAT, MED

  • Brinker International Options Activity: Brinker International, Inc. (EAT) experienced significant options trading with 12,346 contracts, primarily focused on the $100 strike put option expiring November 21, 2025, which saw 5,445 contracts traded.

  • Medifast Inc Options Activity: Medifast Inc (MED) also had notable options trading, with 1,190 contracts traded, particularly for the $10 strike call option expiring June 18, 2026, which accounted for 875 contracts.

  • Trading Volume Context: The options trading volumes for both companies represented a substantial percentage of their average daily trading volumes over the past month, with EAT at 75.1% and MED at 74.3%.

  • Further Information: For more details on available expirations for options related to RKLB, EAT, or MED, StockOptionsChannel.com can be visited.

[object Object]
Preview
4.5
10-27Newsfilter
Medifast Unveils Strategic Transition to Focus on Metabolic Health with Launch of Metabolic Synchronization™

  • Strategic Transformation: Medifast has shifted its focus from solely weight loss to a broader emphasis on holistic metabolic health, introducing Metabolic Synchronization™ to reverse metabolic dysfunction and improve overall health.

  • Addressing Metabolic Dysfunction: With a significant portion of U.S. adults facing metabolic health issues, Medifast aims to tackle the root causes of metabolic dysfunction, promoting effective weight loss while enhancing metabolic function and vitality.

  • Innovative Approach: The Metabolic Synchronization™ system targets visceral fat reduction, preserves lean mass, and supports muscle health, leading to improved body composition and metabolic health beyond just weight loss.

  • Future Innovations: Medifast plans to launch new products in 2026 that utilize the science of metabolic synchronization, continuing its commitment to evidence-based solutions and personalized support through a network of independent coaches.

[object Object]
Preview
9.5
10-21Newsfilter
Medifast to Release Third Quarter Financial Results for the Period Ending September 30, 2025

  • Financial Results Announcement: Medifast will announce its financial results for Q3 2025 on November 3, 2025, after market close, followed by a conference call at 4:30 p.m. ET to discuss the results.

  • Conference Call Details: The call will be accessible via the Medifast website and by telephone, with a playback option available from November 3 to November 10, 2025.

  • Company Overview: Medifast is a health and wellness company focused on weight management and lifestyle change, utilizing a science-backed, coach-guided system supported by extensive research and a network of independent coaches.

  • Commitment to Health: With over 40 years of experience, Medifast aims to address metabolic health issues through innovative science and community support, promoting lifelong transformation and healthy living.

Sign Up For More News

People Also Watch

FAQ

arrow icon

What is Medifast Inc (MED) stock price today?

The current price of MED is 10.86 USD — it has decreased -1.36 % in the last trading day.

arrow icon

What is Medifast Inc (MED)'s business?

Medifast, Inc. is a health and wellness company. The Company is engaged in offering habit-based and coach-guided lifestyle solution, OPTAVIA, which provides people with a comprehensive approach to address obesity and support a healthy lifestyle. OPTAVIA provides coaching support along with community, tailored nutrition, and healthy habits, and helps people in their weight-loss journey through each stage of life. Through its collaboration with national virtual primary care provider LifeMD, Inc. and its affiliated medical group, customers have access to GLP-1 medications where clinically appropriate. It sells a variety of weight-loss, weight management and healthy living products all based on its proprietary formulas under the OPTAVIA, OPTAVIA ACTIVE, and Optimal Health brands. Its product line includes approximately 79 consumable options, including bars, puffs, cereal, crunchers, drinks, hearty choices, oatmeal, pancakes, pudding, soft serve, shakes, smoothies, soft bakes, and soups.

arrow icon

What is the price predicton of MED Stock?

Wall Street analysts forecast MED stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for MED is  USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

arrow icon

What is Medifast Inc (MED)'s revenue for the last quarter?

Medifast Inc revenue for the last quarter amounts to 89.41M USD, decreased -36.21 % YoY.

arrow icon

What is Medifast Inc (MED)'s earnings per share (EPS) for the last quarter?

Medifast Inc. EPS for the last quarter amounts to -0.21 USD, decreased -310.00 % YoY.

arrow icon

What changes have occurred in the market's expectations for Medifast Inc (MED)'s fundamentals?

The market is revising Downward the revenue expectations for Medifast, Inc. (MED) for FY2025, with the revenue forecasts being adjusted by -0.7% over the past three months. During the same period, the stock price has changed by -19.85%.
arrow icon

How many employees does Medifast Inc (MED). have?

Medifast Inc (MED) has 504 emplpoyees as of December 05 2025.

arrow icon

What is Medifast Inc (MED) market cap?

Today MED has the market capitalization of 119.37M USD.

Intellectia LogoIntellectiaIntellectia LogoIntellectia

Redefine Your Investment Decisions

TwitterTwitterYoutubeYoutubeQuoraQuoraDiscordDiscordLinkedinLinkedinTelegramTelegram
AppStoreGooglePlay

Copyright © 2025 Intellectia.AI. All Rights Reserved.

pci certified logo
Company
HomeContactAbout UsNews Release
Compare
TradingViewSeeking Alpha
Features
Financial AI AgentStock Technical AnalysisStock MonitorHedge Fund TrackerAI ScreenerDaytrading Center
Strategies
AI Stock PickerSwing TradingStock Chart PatternsEarnings TradingDaytrading CenterAI Earnings PredictionQuant AIWhales Auto TrackerBacktesting Playground
Free Tools
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Resource
BlogTutorialEarningsTrending StocksCrypto MarketPartner ProgramTerms of UsePrivacy PolicySecuritySitemap
Start for Free